LifeSci Capital Begins Coverage Of Aradigm To Address Non-Cystic Fibrosis Bronchiectasis
News
LifeSci Capital, LLC, a research-driven investment bank with proven experience and expertise in the field of life sciences sector recently announced the initiation of coverage for Aradigm. Aradigm is currently advancing inhaled ciprofloxacin antibiotics to better address chronic ... Read more